BioLase Technology Inc.: The San Clemente dental...
BioLase Technology Inc.: The San Clemente dental products company reported a net loss of $3.1 million, or 40 cents a share, for last year, an improvement over its net loss of $7.5 million, or $1.57 a share, for the previous year. Sales declined 54% to $1.1 million from $2.4 million. For the fourth quarter, the net loss totaled $1.6 million, or 19 cents a share, compared with a net loss of $2.4 million, or 40 cents a share, for the previous year’s final quarter. Sales dropped to $117,246 for the quarter from $779,171.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.